Symbol="TERN"
AssetType="Common Stock"
Name="Terns Pharmaceuticals Inc"
Description="Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. The company is headquartered in Foster City, California."
CIK="1831363"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="380323000"
EBITDA="-79083000"
PERatio="None"
PEGRatio="None"
BookValue="4.489"
DividendPerShare="0"
DividendYield="0"
EPS="-1.25"
RevenuePerShareTTM="0.035"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.229"
ReturnOnEquityTTM="-0.35"
RevenueTTM="1000000"
GrossProfitTTM="1000000"
DilutedEPSTTM="-1.25"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="256.53"
PriceToBookRatio="1.339"
EVToRevenue="60.08"
EVToEBITDA="-1.033"
Beta="-1.11"
num_52WeekHigh="14.04"
num_52WeekLow="2.91"
num_50DayMovingAverage="8.96"
num_200DayMovingAverage="9.23"
SharesOutstanding="56680000"
DividendDate="None"
ExDividendDate="None"
symbol="TERN"
open="6.32"
high="6.84"
low="6.28"
price="6.71"
volume="660506.00"
latest_trading_day="2023-08-11"
previous_close="6.36"
change="0.35"
change_percent="5.5031%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="34"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="720237"
Change_recent_avg="-0.07"
Delta_recent_avg="0.81"
Variance_recent_avg="0.41"
Change_ratio_recent_avg="-0.88"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="1105"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0138.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="528"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="621"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0087.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
